First Interstate Bank’s Anika Therapeutics ANIK Stock Holding History

First Interstate Bank’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-100	Closed	-$5K	–	760
2016 Q2	$5K	Hold	100	–	–	﹤0.01%	617
2016 Q1	$4K	Hold	100	–	–	﹤0.01%	646
2015 Q4	$4K	Hold	100	–	–	﹤0.01%	663
2015 Q3	$3K	Buy	+100	New	+$3.49K	﹤0.01%	716

Other funds holding ANIK

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

First Interstate Bank's ANIK Position: Q3 2016 in Review

First Interstate Bank sold out of Anika Therapeutics (ANIK) in Q3 2016, closing a stake of 100 shares — an estimated $5K sold.

First Interstate Bank first reported a position in ANIK in Q3 2015 and held it in 4 quarters. The position peaked at $5K in Q2 2016. 163 funds tracked by Wall St. Rank hold ANIK as of Q3 2016.

First Interstate Bank reported no remaining Anika Therapeutics position as of Q3 2016 after selling out during the quarter.
First Interstate Bank sold 100 Anika Therapeutics shares in Q3 2016, an estimated $5K.
First Interstate Bank first reported a position in Anika Therapeutics in Q3 2015 and held it in 4 quarters.
First Interstate Bank's Anika Therapeutics position peaked at $5K in Q2 2016.
163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2016.

Based on First Interstate Bank's 13F filing for Q3 2016, filed 10 Nov 2016.